您的购物车当前为空
Aspalatone is an anti-platelet aggregator (IC50 = 180 μM, in vitro) that prolongs bleeding time significantly in a rodent model of thromboembolism. Additionally at a minimal effective dose of 24 mg/kg, aspalatone generates antioxidant and neuroprotective effects against kainic acid-induced epilepsy in rat hippocampus.

Aspalatone is an anti-platelet aggregator (IC50 = 180 μM, in vitro) that prolongs bleeding time significantly in a rodent model of thromboembolism. Additionally at a minimal effective dose of 24 mg/kg, aspalatone generates antioxidant and neuroprotective effects against kainic acid-induced epilepsy in rat hippocampus.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥ 913 | 35日内发货 | |
| 10 mg | ¥ 1,660 | 35日内发货 | |
| 50 mg | ¥ 6,930 | 35日内发货 | |
| 100 mg | ¥ 12,000 | 35日内发货 |
Aspalatone 相关产品
| 产品描述 | Aspalatone is an anti-platelet aggregator (IC50 = 180 μM, in vitro) that prolongs bleeding time significantly in a rodent model of thromboembolism. Additionally at a minimal effective dose of 24 mg/kg, aspalatone generates antioxidant and neuroprotective effects against kainic acid-induced epilepsy in rat hippocampus. |
| 分子量 | 288.25 |
| 分子式 | C15H12O6 |
| CAS No. | 147249-33-0 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度信息 | Ethanol: 1 mg/mL (3.47 mM), Sonication is recommended. DMSO: 10 mg/mL (34.69 mM), Sonication is recommended. DMF: 10 mg/mL (34.69 mM), Sonication is recommended. DMSO:PBS (pH 7.2) (1:10): 0.1 mg/mL (0.35 mM), Sonication is recommended. |
评论内容